Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 85650-52-8 | Product Number: M2151
Mirtazapine
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
Product Documents:
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
|---|---|---|---|---|---|
| 100MG |
$83.00
|
3 | 1 | 8 |
|
| 1G |
$406.00
|
1 | 1 | 30 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | M2151 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__7H__1__9N__3 = 265.36 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 85650-52-8 |
| Reaxys Registry Number | 549345 |
| PubChem Substance ID | 125307817 |
| SDBS (AIST Spectral DB) | 52906 |
| MDL Number | MFCD00865427 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
| Melting point | 119.0 to 123.0 °C |
Properties (reference)
| Melting Point | 121 °C |
GHS
Related Laws:
| RTECS# | UQ4410250 |
Transport Information:
| HS Number | 2934.99.4400 |
Application
Mirtazapine: A Noradrenergic and Specific Serotonergic Antidepressant (NaSSA)
Mirtazapine (Org 3770) is the first noradrenergic and specific serotonergic antidepressant (NaSSA). Studies have suggested that mirtazapine acts as an antagonist at central presynaptic α2 adrenergic inhibitory autoreceptors and heteroreceptors, as well as by blocking 5-HT2 and 5-HT3 receptors. Therefore, these antagonisms enhance the release of noradrenaline and 5-HT1A-mediated serotonergic transmission in brain. Mirtazapine is mainly metabolized by CYP1A2, CYP2D6, and CYP3A4. (The product is for research purpose only.)
References
- Neurochemical and autonomic pharmacological profiles of the 6-aza-analog of mianserin, Org 3770 and its enantiomers
- Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain.
- A review of the pharmacological and clinical profile of mirtazapine
- High-Performance Liquid Chromatographic Method with Diode Array Detection for Identification and Quantification of the Eight New Antidepressants and Five of Their Active Metabolites in Plasma after Overdose
- Chirality in the New Generation of Antidepressants: Stereoselective Analysis of the Enantiomers of Mirtazapine, N-Demethylmirtazapine, and 8-Hydroxymirtazapine by LC-MS
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.